Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
A dedicated Phase 3 trial evaluating retatrutide specifically for metabolic dysfunction-associated steatotic liver disease is currently underway
The percentages above are from separate trials with different populations and durations, so direct comparison requires caution
From pharmacy to pantry How GLP-1 drugs are shifting consumer preferences and shopping patterns Wells Fargo Agri-Food Institute digs into the data with NielsenIQ on GLP-1 use, consumer purchase trends, and how companies can tip the scales in favor of more profitability
The underlying cause, slowed gut motility from receptor activation, produces similar constipation characteristics regardless of which receptors are targeted
US$ 24.74
US$ 28.18
US$ 23.73
US$ 28.80
US$ 26.84
US$ 22.57
US$ 20.07
